The nearly $19 million boost comes after the Inflation Reduction Act extended enhanced premium tax credits for ACA marketplaces policies through 2025.
The Biden administration announced today that it was increasing funding for Affordable Care Act (ACA) navigators by almost $19 million.
“This is a historic investment to connect people to high-quality, affordable health care,” said Health and Human Services Secretary Xavier Becerra in a press release.
“Along with increased premium subsidies there’s no question President Biden has followed through on reinvigorating the ACA,” tweeted Larry Levitt, executive vice president of the Kaiser Family Foundation.
The administration allocated $80 million for navigators in 2021, which it says resulted in a workforce of 1,500 certified navigators. This year it is increasing the navigator funds to $98.9 million. The money is distributed to state and local organizations that hire and train navigators.
Open enrollment for 2023 ACA marketplace plans starts Nov. 1 and ends Jan. 15, 2023. Last year, 14.1 million people selected an ACA marketplace plan during the open enrollment.
The Trump administration cut navigator funding to $10 million annually.
The boost in funds for navigators comes on the heels of the passage of the Inflation Reduction Act, which has several provisions that bolster the ACA, most notably the extension for three years of the enhanced premium subsidies that were part of the American Rescue Plan Act of 2021.The enhanced premium subsides work in two ways. They lower the share of income that people with low and middle incomes must pay toward a premium for a middle-range ACA “silver” plan. They also extended the subsides, which come in the form of tax credits, to people with higher incomes, specifically 400% of the federal poverty line and above. Previously, the subsidies ended abruptly at 400% of the federal poverty line.
Differences in Defining “Clinically Meaningful” in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis
October 4th 2024Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the symptoms, epidemiology diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) in a Managed Healthcare Executive K-Cast video series.
Read More
Differences in Defining “Clinically Meaningful” in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis
October 4th 2024Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the symptoms, epidemiology diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) in a Managed Healthcare Executive K-Cast video series.
Read More
2 Commerce Drive
Cranbury, NJ 08512